Finland
VEIL.AI, founded in 2019 and headquartered in Finland, is a pioneering force in the domain of sensitive data handling, specifically within the healthcare industry. Their slogan, "Enable use of sensitive data with next-generation anonymization," captures their mission succinctly.
The company's core strength lies in its patented technology that facilitates the anonymization of health data, allowing for its secure and effective use. This technology is vital for overcoming challenges such as access and integration of complex, siloed data. By transforming sensitive information into actionable intelligence, VEIL.AI enhances the utility of health data while maintaining strict privacy protocols.
Their AI-driven solutions offer significant benefits to various healthcare stakeholders, including hospitals, pharma companies, and tech firms focused on wearables and IoT. With capabilities ranging from decentralized clinical trials to the development of AI algorithms for superior patient care, VEIL.AI is positioned as a key player in advancing Real World Evidence and evidence generation efficiency.
In August 2024, VEIL.AI secured a grant investment from DayOne, highlighting confidence in its innovative technology and potential for scaling. Investors interested in the burgeoning field of health data technology will find VEIL.AI to be a promising opportunity.
